Rapid seizure detection at the point of care
Ceribell (ceribell.com) scores 79 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, Technology brands, in the 67th percentile of 5333 Healthcare brands.
Ceribell is a healthcare technology company that provides a point-of-care EEG solution designed to help hospitals rapidly triage and continuously monitor patients at risk for seizures. Its system enables clinicians without specialized neurology training to detect and monitor non-convulsive seizures quickly, particularly in emergency departments, ICUs, and smaller hospitals with limited neurology resources. The company positions its technology as a bridge between critical care and specialized neurological diagnostics.
| Brand Name | Ceribell |
|---|---|
| Domain | ceribell.com |
| Industry | Healthcare, Technology |
| Main Competitors | Natus Medical (66/100), Nihon Kohden (73/100), Persyst Development Corporation (84/100), Zeto, BrainScope, Compumedics (74/100), GE Healthcare (89/100), Philips (82/100) |
Moz Domain Authority 36/100 vs category average 39 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
Ranked #1,238,691 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Triage and continuously monitor hospital patients at risk for seizures in minutes with Ceribell's point-of-care EEG solution. Learn more." (Meta description: 19 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 2 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Nginx, WordPress, Ghost.
Social footprint: verified profiles on LinkedIn, YouTube, X (Twitter), Instagram, Facebook, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked August 2026.
When asked "What is Ceribell?", Claude could identify the brand as of August 2026. Ceribell is a medical device company that makes a rapid point-of-care EEG system designed to help clinicians detect seizures at the bedside within minutes, primarily used in emergency rooms and ICUs. Their device uses a headband-style electrode setup paired with AI-driven softwar Best known for Rapid, easy-to-apply point-of-care EEG headband for bedside seizure detection.
When asked "Best brands similar to Ceribell?", Claude would recommend Ceribell as of August 2026. It's a notable and well-known player in the point-of-care neuromonitoring space, so it would come up naturally in a discussion of similar healthcare tech brands.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Ceribell's main competitors in Healthcare: Natus Medical (66/100), Nihon Kohden (73/100), Persyst Development Corporation (84/100), Compumedics (74/100), GE Healthcare (89/100).
Sources: Brand Analyzer scan
Ceribell has limited AI-search visibility, scoring 29/100 on Brand Analyzer's AI visibility composite (visibility 13, trust 39, recommendation 45). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Ceribell official site
Ceribell offers a point-of-care EEG solution used for rapid triage and continuous monitoring of hospital patients at risk for seizures, including detection of non-convulsive seizures.
Sources: Ceribell official site
Ceribell provides technology that allows hospital staff to rapidly triage and continuously monitor patients at risk for seizures using point-of-care EEG. The system is designed to be used by clinicians who do not have specialized neurology expertise, enabling faster detection of non-convulsive seizures in settings such as emergency departments, ICUs, and smaller hospitals.
Sources: Ceribell official site
Ceribell scores 45/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Ceribell official site
Ceribell is a healthcare technology company that develops a point-of-care EEG (electroencephalogram) solution used in hospitals to detect and monitor seizures, particularly non-convulsive seizures, in critically ill patients.
Sources: Ceribell official site
Ceribell can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Ceribell official site
Ceribell's technology is used by hospitals, emergency departments, ICUs, and healthcare providers who need rapid and accurate seizure detection and monitoring for critically ill patients, including in settings without dedicated neurology specialists.
Sources: Ceribell official site
Ceribell is known for its point-of-care EEG device that enables rapid, easy-to-use seizure detection and continuous monitoring for critically ill patients, especially in settings lacking dedicated neurology specialists.
Sources: Ceribell official site
Ceribell scores 29/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Ceribell has a weak AI-visibility profile at 29/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (45/100) and its weakest is visibility (13/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #1,238,691 (Tranco) and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 36/100 and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Ceribell from memory (August 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Ceribell: Cerebral (79/100), Limber (Net Health) (79/100), Cervey (79/100), Community Health Systems (79/100).
A step up - brands to learn from: Zurich Insurance Group (81/100), Zeel (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.